In patients with newly diagnosed multiple sclerosis (MS) of different ethnicities there are no differences in early cognitive impairment.
Why this matters
Subtle cognitive impairment in early-MS predicts disabling cognitive impairment later in disease course.
Early intervention may prevent or delay neurodegeneration and improve cognition.
No ethnic subgroup has yet been identified as at greater risk of early cognitive impairment.
Want to read more?
Log in or sign up to access all Neurodiem content.
Already have an account? Log In
International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.